168 related articles for article (PubMed ID: 17128659)
1. Switching in the era of atypical antipsychotics. An updated review.
Weiden PJ
Postgrad Med; 2006 Sep; Spec No():27-44. PubMed ID: 17128659
[TBL] [Abstract][Full Text] [Related]
2. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
3. Switching antipsychotics: an updated review with a focus on quetiapine.
Weiden PJ
J Psychopharmacol; 2006 Jan; 20(1):104-18. PubMed ID: 16204323
[TBL] [Abstract][Full Text] [Related]
4. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 4():34-9. PubMed ID: 17539698
[TBL] [Abstract][Full Text] [Related]
5. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
6. Long-term considerations after switching antipsychotics.
Weiden PJ; Aquila R; Emanuel M; Zygmunt A
J Clin Psychiatry; 1998; 59 Suppl 19():36-49. PubMed ID: 9847051
[TBL] [Abstract][Full Text] [Related]
7. The art and science of switching of antipsychotic medications, part 1.
Weiden PJ; Young AH; Buckley PF
J Clin Psychiatry; 2006 Nov; 67(11):e15. PubMed ID: 17201045
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
9. The safety and tolerability of atypical antipsychotics in bipolar disorder.
Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
[TBL] [Abstract][Full Text] [Related]
10. Switching approach in the management of schizophrenia patients.
Peuskens J
Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S15-9. PubMed ID: 11252519
[TBL] [Abstract][Full Text] [Related]
11. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
Correll CU
J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
[TBL] [Abstract][Full Text] [Related]
12. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
13. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
Taylor D; Hayhurst K; Kerwin R
Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
[TBL] [Abstract][Full Text] [Related]
14. Some adverse effects of antipsychotics: prevention and treatment.
Lader M
J Clin Psychiatry; 1999; 60 Suppl 12():18-21. PubMed ID: 10372605
[TBL] [Abstract][Full Text] [Related]
15. Effects of antipsychotics on brain structure.
Scherk H; Falkai P
Curr Opin Psychiatry; 2006 Mar; 19(2):145-50. PubMed ID: 16612194
[TBL] [Abstract][Full Text] [Related]
16. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
18. Prolactin awareness: an essential consideration for physical health in schizophrenia.
Montejo AL
Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
[TBL] [Abstract][Full Text] [Related]
19. Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.
Covell NH; Jackson CT; Weissman EM
Postgrad Med; 2006 Sep; Spec No():20-6. PubMed ID: 17128658
[TBL] [Abstract][Full Text] [Related]
20. Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.
Weiden PJ; Preskorn SH; Fahnestock PA; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2007; 68 Suppl 7():1-48. PubMed ID: 17650057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
